Skip to Content

Asclera (polidocanol) Disease Interactions

There is 1 disease interaction with Asclera (polidocanol):

Major

Polidocanol (Includes Asclera) ↔ thromboembolic disease

Severe Potential Hazard, Moderate plausibility. Applies to: Thrombotic/Thromboembolic Disorder

Polidocanol is a sclerosing agent that locally damages the endothelium of blood vessels. When injected intravenously, polidocanol induces endothelial damage. The use of polidocanol is contraindicated in patients with acute thromboembolic diseases.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide